Search Ontology:
ChEBI
eliglustat
- Term ID
- CHEBI:82752
- Synonyms
-
- eliglustat
- Genz 99067
- Genz-99067
- N-[(1R,2R)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl]octanamide
- Definition
- A carboxamide obtained by formal condensation of the carboxy group of octanoic acid with the primary amino group of (1R,2R)-2-amino-1-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(pyrrolidin-1-yl)propan-1-ol. A ceramide glucosyltransferase inhibitor used (as its tartrate salt) for treatment of Gaucher's disease.
- References
-
- CAS:491833-29-5
- Drug_Central:4834
- KEGG:D09893
- PMID:20439622
- PMID:20713962
- PMID:20864621
- PMID:20872320
- PMID:22563139
- PMID:24816856
- PMID:24835462
- PMID:25239269
- Reaxys:21475293
- Wikipedia:Eliglustat
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_role
-
- inverse is_conjugate_acid_of
-
- is_conjugate_base_of
-
Phenotype
Phenotype resulting from eliglustat
Phenotype where environments contain eliglustat
Phenotype modified by environments containing eliglustat
Human Disease Model